Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
暂无分享,去创建一个
Giuseppe Basso | Richard Ratei | Michael N Dworzak | Andrea Biondi | G. Basso | A. Biondi | M. Dworzak | Giuseppe Gaipa | Marinella Veltroni | Oscar Maglia | G. Gaipa | R. Ratei | M. Veltroni | Lucia De Zen | Maria Colomba Sanzari | M. Sanzari | O. Maglia | L. De Zen
[1] Elaine Coustan-Smith,et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia , 1998, The Lancet.
[2] W. Kamps,et al. Regenerating normal B‐cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease , 2000, British journal of haematology.
[3] M. Borowitz,et al. Asynchronous Antigen Expression in B Lineage Acute Lymphoblastic Leukemia , 1988 .
[4] P. Lacor,et al. Different expression of adhesion molecules on CD34+ cells in AML and B‐lineage ALL and their normal bone marrow counterparts , 1999, European journal of haematology.
[5] C. V. D. Schoot,et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia , 2000, Leukemia.
[6] Michael N Dworzak,et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. , 2002, Blood.
[7] D. Printz,et al. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. , 1998, Experimental hematology.
[8] A. Órfão,et al. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification , 2000, Leukemia.
[9] A Orfao,et al. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Cavé,et al. Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia , 1998 .
[11] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998 .
[12] J. Gabert,et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects , 2003, Leukemia.
[13] A. Órfão,et al. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation. , 2001, Leukemia.
[14] G. Janossy,et al. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression. , 1994, Cytometry.
[15] Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. , 2000 .
[16] D. Campana,et al. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. , 2001, Blood.
[17] H. Gralnick,et al. The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations , 1981, British journal of haematology.
[18] M. Stul,et al. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease , 1998, Leukemia.
[19] F. Behm,et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. , 2002, Blood.
[20] D. Campana,et al. Detection of minimal residual disease in acute leukemia by flow cytometry. , 1999, Cytometry.
[21] O. Haas,et al. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods. , 1999, Experimental hematology.
[22] Jennings Cd,et al. Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy , 1997 .
[23] L. Picker,et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. , 2001, Blood.
[24] A Orfao,et al. New methodologic approaches for immunophenotyping acute leukemias. , 2001, Haematologica.
[25] H. Hooijkaas,et al. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy , 2000, Leukemia.